Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
3D Systems expands joint development bioprinting pact with United Therapeutics » 16:38
10/27/21
10/27
16:38
10/27/21
16:38
DDD

3D Systems

$27.02 /

-1.67 (-5.82%)

, UTHR

United Therapeutics

$186.23 /

-3.97 (-2.09%)

3D Systems (DDD) …

3D Systems (DDD) announces an expansion of its joint development program with United Therapeutics (UTHR). The development and license agreement, first established in 2017, combines the 3D printing expertise of 3D Systems, with the regenerative medicine and organ manufacturing expertise of United Therapeutics. To date, the program has had a strong, singular focus on developing the capability to print scaffolds for human lungs using a process we call Print to Perfusion. This 3D printed scaffold would then be cellularized using cells derived from the recipient patient's own body, to create personalized human lungs. 3D Systems has focused primarily on establishing the printing technology to produce scaffolds meeting the extreme precision and resolution requirements for a functional human lung and to do so in a manner that yields the physical, mechanical, and biocompatibility performance to influence cell behavior and reproduction required for extended use in the human body. The goal of the program is to establish an unlimited supply of human lungs, requiring no immunosuppression, allowing all patients with end-stage lung disease to receive transplants which will enable them to enjoy long and active lives. Based upon the progress made toward this goal, the program is now being expanded to include two additional human organs, with support now designated through 2025."

ShowHide Related Items >><<
UTHR United Therapeutics
$186.23 /

-3.97 (-2.09%)

DDD 3D Systems
$27.02 /

-1.67 (-5.82%)

DDD 3D Systems
$27.02 /

-1.67 (-5.82%)

08/13/21 Loop Capital
3D Systems price target raised to $33 from $24 at Loop Capital
08/10/21 Craig-Hallum
3D Systems downgraded to Hold at Craig-Hallum after 'outsized' move higher
08/10/21 Craig-Hallum
3D Systems downgraded to Hold from Buy at Craig-Hallum
07/28/21 Craig-Hallum
Craig-Hallum bullish 3D Systems after Simbionix divesture at attractive multiple
UTHR United Therapeutics
$186.23 /

-3.97 (-2.09%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
UTHR United Therapeutics
$186.23 /

-3.97 (-2.09%)

DDD 3D Systems
$27.02 /

-1.67 (-5.82%)

UTHR United Therapeutics
$186.23 /

-3.97 (-2.09%)

DDD 3D Systems
$27.02 /

-1.67 (-5.82%)

DDD 3D Systems
$27.02 /

-1.67 (-5.82%)

Over a week ago
On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:54
10/18/21
10/18
12:54
10/18/21
12:54
M

Macy's

$27.30 /

+3.26 (+13.56%)

, Z

Zillow

$86.60 /

-8.34 (-8.78%)

, ZG

Zillow Group

$86.25 /

-8.05 (-8.54%)

, CDW

CDW

$185.50 /

+7.81 (+4.40%)

, TM

Toyota

$178.41 /

+2.155 (+1.22%)

, AAPL

Apple

$145.33 /

+0.54 (+0.37%)

, DIS

Disney

$170.73 /

-5.695 (-3.23%)

, SPCE

Virgin Galactic

$19.71 /

-0.29 (-1.45%)

, MDT

Medtronic

$121.10 /

-6.55 (-5.13%)

, INFN

Infinera

$7.67 /

-0.4 (-4.96%)

, NTAP

NetApp

$90.91 /

-3.485 (-3.69%)

, NFLX

Netflix

$634.29 /

+6.61 (+1.05%)

, BABA

Alibaba

$168.41 /

+0.35 (+0.21%)

, GS

Goldman Sachs

$414.61 /

+8.49 (+2.09%)

, ASLE

AerSale

$18.32 /

+0.37 (+2.06%)

, BTU

Peabody Energy

$19.19 /

+3.215 (+20.13%)

, AR

Antero Resources

$20.19 /

+0.6 (+3.06%)

, OMER

Omeros

$5.81 /

-1.93 (-24.94%)

, MNKD

MannKind

$4.13 /

-0.975 (-19.12%)

, UTHR

United Therapeutics

$182.52 /

-4.67 (-2.49%)

, LTCH

Latch

$9.06 /

-1.88 (-17.18%)

, STT

State Street

$96.37 /

+3.63 (+3.91%)

, ACI

Albertsons

$29.42 /

+0.9 (+3.16%)

, CLAR

Clarus

$29.21 /

+1.46 (+5.26%)

, LHCG

LHC Group

$140.64 /

-4.36 (-3.01%)

, MBCN

Middlefield Banc

$24.00 /

+0.73 (+3.14%)

Get caught up quickly on…

ShowHide Related Items >><<
Z Zillow
$86.60 /

-8.34 (-8.78%)

UTHR United Therapeutics
$182.52 /

-4.67 (-2.49%)

TM Toyota
$178.41 /

+2.155 (+1.22%)

STT State Street
$96.37 /

+3.63 (+3.91%)

SPCE Virgin Galactic
$19.71 /

-0.29 (-1.45%)

OMER Omeros
$5.81 /

-1.93 (-24.94%)

NTAP NetApp
$90.91 /

-3.485 (-3.69%)

NFLX Netflix
$634.29 /

+6.61 (+1.05%)

MNKD MannKind
$4.13 /

-0.975 (-19.12%)

MDT Medtronic
$121.10 /

-6.55 (-5.13%)

MBCN Middlefield Banc
$24.00 /

+0.73 (+3.14%)

M Macy's
$27.30 /

+3.26 (+13.56%)

LTCH Latch
$9.06 /

-1.88 (-17.18%)

LHCG LHC Group
$140.64 /

-4.36 (-3.01%)

INFN Infinera
$7.67 /

-0.4 (-4.96%)

GS Goldman Sachs
$414.61 /

+8.49 (+2.09%)

DIS Disney
$170.73 /

-5.695 (-3.23%)

CLAR Clarus
$29.21 /

+1.46 (+5.26%)

CDW CDW
$185.50 /

+7.81 (+4.40%)

BTU Peabody Energy
$19.19 /

+3.215 (+20.13%)

BABA Alibaba
$168.41 /

+0.35 (+0.21%)

ASLE AerSale
$18.32 /

+0.37 (+2.06%)

AR Antero Resources
$20.19 /

+0.6 (+3.06%)

ACI Albertsons
$29.42 /

+0.9 (+3.16%)

AAPL Apple
$145.33 /

+0.54 (+0.37%)

M Macy's
$27.30 /

+3.26 (+13.56%)

09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Gordon Haskett
Macy's upgraded to Buy from Hold at Gordon Haskett
09/09/21 Cowen
Cowen upgrades Macy's to Outperform, sees 'American icon reinvented'
09/09/21
Fly Intel: Top five analyst upgrades
Z Zillow
$86.60 /

-8.34 (-8.78%)

10/18/21 Piper Sandler
Zillow Group price target lowered to $117 from $174 at Piper Sandler
09/22/21 Piper Sandler
August home data positive for Zillow and Redfin, says Piper Sandler
08/09/21 Zelman
Zillow upgraded to Buy from Hold at Zelman
08/06/21 Morgan Stanley
Morgan Stanley trims Zillow price target to $153, sees iBuying re-rating lower
ZG Zillow Group
$86.25 /

-8.05 (-8.54%)

10/04/21 RBC Capital
Zillow Group price target lowered to $145 from $155 at RBC Capital
09/16/21 BTIG
Zillow Group price target lowered to $145 from $185 at BTIG
CDW CDW
$185.50 /

+7.81 (+4.40%)

10/06/21
Fly Intel: Top five analyst downgrades
10/06/21 Morgan Stanley
CDW downgraded to Equal Weight from Overweight at Morgan Stanley
10/05/21 Morgan Stanley
CDW downgraded to Equal Weight from Overweight at Morgan Stanley
09/29/21 JPMorgan
CDW upgraded to Neutral from Underweight at JPMorgan
TM Toyota
$178.41 /

+2.155 (+1.22%)

10/18/21 Bernstein
Bernstein still 'struggles' with Tesla stock valuation
10/12/21 Morgan Stanley
Toyota initiated with an Overweight at Morgan Stanley
09/16/21 Morgan Stanley
XPeng 'aiming to redefine mass-market EVs' with P5, says Morgan Stanley
03/30/21 Citi
Toyota resumed with a Buy at Citi
AAPL Apple
$145.33 /

+0.54 (+0.37%)

10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/15/21 Evercore ISI
Evercore ISI thinks Apple can become 'serious player in the advertising market'
10/14/21 Needham
Needham cuts Apple iPhone 13 shipment estimates for calendar Q4
10/14/21 Citi
Apple likely to sound more cautious due to supply chain, says Citi
DIS Disney
$170.73 /

-5.695 (-3.23%)

10/18/21
Fly Intel: Top five analyst downgrades
10/18/21 MoffettNathanson
Disney price target lowered to $180 from $185 at MoffettNathanson
10/18/21 Barclays
Barclays downgrades Disney on slowing of streaming growth
10/18/21 Barclays
Disney downgraded to Equal Weight from Overweight at Barclays
SPCE Virgin Galactic
$19.71 /

-0.29 (-1.45%)

10/18/21 UBS
Virgin Galactic downgraded to Sell from Neutral at UBS
10/18/21 UBS
Virgin Galactic downgraded to Sell from Neutral at UBS
10/15/21 Canaccord
Virgin Galactic flight delay not significant to long-term plans, says Canaccord
10/15/21 BofA
Virgin Galactic price target lowered to $20 from $25 at BofA
MDT Medtronic
$121.10 /

-6.55 (-5.13%)

10/18/21 Morgan Stanley
Medtronic bias positive at Morgan Stanley despite 'not optimal' ON MED update
10/18/21 Wells Fargo
Medtronic price target lowered to $144 from $151 at Wells Fargo
10/18/21 Piper Sandler
Medtronic growth pathway now 'a little riskier,' says Piper Sandler
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
INFN Infinera
$7.67 /

-0.4 (-4.96%)

10/18/21 JPMorgan
Infinera downgraded to Underweight on supply chain risk at JPMorgan
10/18/21 JPMorgan
Infinera downgraded to Underweight from Neutral at JPMorgan
09/24/21
Fly Intel: Top five analyst downgrades
09/24/21 MKM Partners
Infinera downgraded to Neutral from Buy at MKM Partners
NTAP NetApp
$90.91 /

-3.485 (-3.69%)

10/18/21 Goldman Sachs
NetApp downgraded to Sell from Neutral at Goldman Sachs
10/14/21 Citi
NetApp upgraded to Buy from Sell at Citi
09/29/21 JPMorgan
NetApp price target raised to $108 from $95 at JPMorgan
09/09/21 Morgan Stanley
NetApp price target raised to $102 from $96 at Morgan Stanley
NFLX Netflix
$634.29 /

+6.61 (+1.05%)

10/18/21 Loop Capital
Netflix price target raised to $700 from $650 at Loop Capital
10/18/21 UBS
Netflix price target raised to $720 from $620 at UBS
10/15/21 Morgan Stanley
Netflix price target raised to $675 from $650 at Morgan Stanley
10/15/21 Evercore ISI
Netflix added to 'Tactical Outperform List' at Evercore ISI
BABA Alibaba
$168.41 /

+0.35 (+0.21%)

10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 KeyBanc
Alibaba price target lowered to $200 from $250 at KeyBanc
10/01/21 Raymond James
Alibaba downgraded to Outperform from Strong Buy at Raymond James
10/01/21 Raymond James
Alibaba downgraded to Outperform from Strong Buy at Raymond James
GS Goldman Sachs
$414.61 /

+8.49 (+2.09%)

10/18/21 RBC Capital
Goldman Sachs price target raised to $435 from $370 at RBC Capital
10/18/21 Oppenheimer
Goldman Sachs price target raised to $576 from $520 at Oppenheimer
10/18/21 Credit Suisse
Goldman Sachs price target raised to $470 from $450 at Credit Suisse
10/18/21 BMO Capital
Goldman Sachs price target raised to $451 from $432 at BMO Capital
ASLE AerSale
$18.32 /

+0.37 (+2.06%)

01/07/21 Cowen
AerSale initiated with a Market Perform at Cowen
BTU Peabody Energy
$19.19 /

+3.215 (+20.13%)

10/04/21 B. Riley
Peabody Energy upgraded to Buy on rising price decks at B. Riley
10/04/21 B. Riley
Peabody Energy upgraded to Buy from Neutral at B. Riley
09/02/21 B. Riley
Peabody Energy price target raised to $15 from $11 at B. Riley
08/02/21 B. Riley
Peabody Energy price target raised to $11 from $7 at B. Riley
AR Antero Resources
$20.19 /

+0.6 (+3.06%)

10/18/21 Mizuho
Antero Resources upgraded to Buy on higher gas prices at Mizuho
10/18/21 Mizuho
Antero Resources upgraded to Buy from Neutral at Mizuho
10/07/21 Truist
Antero Resources price target raised to $23 from $18 at Truist
09/30/21 Northland
Antero Resources price target raised to $32 from $21 at Northland
OMER Omeros
$5.81 /

-1.93 (-24.94%)

10/08/21 JPMorgan
Omeros downgraded to Underweight with CRL likely at JPMorgan
10/08/21 JPMorgan
Omeros downgraded to Underweight from Neutral at JPMorgan
10/06/21 H.C. Wainwright
Omeros price target lowered to $19 from $32 at H.C. Wainwright
10/04/21 Maxim
Omeros cut to Hold at Maxim after another Narsoplimab delay
MNKD MannKind
$4.13 /

-0.975 (-19.12%)

05/13/21 RBC Capital
MannKind initiated with a Sector Perform at RBC Capital
02/26/21 H.C. Wainwright
MannKind price target raised to $6.50 from $2.50 at H.C. Wainwright
02/24/21 BTIG
MannKind price target raised to $8 from $4 at BTIG
12/29/20 BTIG
United Therapeutics' treprostinil development uses MannKind technology, say BTIG
UTHR United Therapeutics
$182.52 /

-4.67 (-2.49%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
LTCH Latch
$9.06 /

-1.88 (-17.18%)

10/18/21 Goldman Sachs
Latch downgraded to Neutral from Buy at Goldman Sachs
10/05/21 BofA
BofA starts Latch at Underperform on execution risk
10/05/21 BofA
Latch initiated with an Underperform at BofA
08/31/21 Benchmark
SmartRent results 'bode well' for Latch, says Benchmark
STT State Street
$96.37 /

+3.63 (+3.91%)

10/07/21 Wolfe Research
State Street upgraded to Outperform from Peer Perform at Wolfe Research
09/24/21 Deutsche Bank
State Street price target lowered to $111 from $120 at Deutsche Bank
09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
ACI Albertsons
$29.42 /

+0.9 (+3.16%)

10/11/21
Fly Intel: Top five analyst downgrades
10/11/21 Deutsche Bank
Albertsons price target raised to $36 from $29 at Deutsche Bank
10/11/21 Oppenheimer
Albertsons downgraded to Perform from Outperform at Oppenheimer
10/05/21
Fly Intel: Top five analyst downgrades
CLAR Clarus
$29.21 /

+1.46 (+5.26%)

08/03/21 DA Davidson
Clarus price target raised to $36 from $31 at DA Davidson
08/03/21 Lake Street
Clarus price target raised to $35 from $33 at Lake Street
07/06/21 Lake Street
Clarus price target raised to $33 from $29 at Lake Street
06/02/21 Lake Street
Clarus price target raised to $29 from $25 at Lake Street
LHCG LHC Group
$140.64 /

-4.36 (-3.01%)

10/18/21 Benchmark
LHC Group price target lowered to $210 from $260 at Benchmark
10/13/21 Truist
LHC Group price target lowered to $185 from $240 at Truist
09/27/21 SVB Leerink
SVB Leerink starts LHC Group at Market Perform on near-term concerns
09/27/21 SVB Leerink
LHC Group initiated with a Market Perform at SVB Leerink
MBCN Middlefield Banc
$24.00 /

+0.73 (+3.14%)

07/29/21 Credit Suisse
Middlefield Banc downgraded to Neutral from Outperform at Credit Suisse
01/29/21 Boenning & Scattergood
Middlefield Banc upgraded to Outperform from Neutral at Boenning & Scattergood
ZG Zillow Group
$86.25 /

-8.05 (-8.54%)

Z Zillow
$86.60 /

-8.34 (-8.78%)

UTHR United Therapeutics
$182.52 /

-4.67 (-2.49%)

TM Toyota
$178.41 /

+2.155 (+1.22%)

STT State Street
$96.37 /

+3.63 (+3.91%)

SPCE Virgin Galactic
$19.71 /

-0.29 (-1.45%)

OMER Omeros
$5.81 /

-1.93 (-24.94%)

NTAP NetApp
$90.91 /

-3.485 (-3.69%)

NFLX Netflix
$634.29 /

+6.61 (+1.05%)

MNKD MannKind
$4.13 /

-0.975 (-19.12%)

MDT Medtronic
$121.10 /

-6.55 (-5.13%)

MBCN Middlefield Banc
$24.00 /

+0.73 (+3.14%)

M Macy's
$27.30 /

+3.26 (+13.56%)

LTCH Latch
$9.06 /

-1.88 (-17.18%)

LHCG LHC Group
$140.64 /

-4.36 (-3.01%)

INFN Infinera
$7.67 /

-0.4 (-4.96%)

GS Goldman Sachs
$414.61 /

+8.49 (+2.09%)

DIS Disney
$170.73 /

-5.695 (-3.23%)

CLAR Clarus
$29.21 /

+1.46 (+5.26%)

CDW CDW
$185.50 /

+7.81 (+4.40%)

BTU Peabody Energy
$19.19 /

+3.215 (+20.13%)

BABA Alibaba
$168.41 /

+0.35 (+0.21%)

AR Antero Resources
$20.19 /

+0.6 (+3.06%)

ACI Albertsons
$29.42 /

+0.9 (+3.16%)

AAPL Apple
$145.33 /

+0.54 (+0.37%)

  • 10
    Sep
Z Zillow
$86.60 /

-8.34 (-8.78%)

TM Toyota
$178.41 /

+2.155 (+1.22%)

STT State Street
$96.37 /

+3.63 (+3.91%)

SPCE Virgin Galactic
$19.71 /

-0.29 (-1.45%)

NFLX Netflix
$634.29 /

+6.61 (+1.05%)

MDT Medtronic
$121.10 /

-6.55 (-5.13%)

M Macy's
$27.30 /

+3.26 (+13.56%)

GS Goldman Sachs
$414.61 /

+8.49 (+2.09%)

DIS Disney
$170.73 /

-5.695 (-3.23%)

BABA Alibaba
$168.41 /

+0.35 (+0.21%)

ASLE AerSale
$18.32 /

+0.37 (+2.06%)

AR Antero Resources
$20.19 /

+0.6 (+3.06%)

ACI Albertsons
$29.42 /

+0.9 (+3.16%)

AAPL Apple
$145.33 /

+0.54 (+0.37%)

ZG Zillow Group
$86.25 /

-8.05 (-8.54%)

Z Zillow
$86.60 /

-8.34 (-8.78%)

TM Toyota
$178.41 /

+2.155 (+1.22%)

STT State Street
$96.37 /

+3.63 (+3.91%)

SPCE Virgin Galactic
$19.71 /

-0.29 (-1.45%)

OMER Omeros
$5.81 /

-1.93 (-24.94%)

NTAP NetApp
$90.91 /

-3.485 (-3.69%)

NFLX Netflix
$634.29 /

+6.61 (+1.05%)

MNKD MannKind
$4.13 /

-0.975 (-19.12%)

MDT Medtronic
$121.10 /

-6.55 (-5.13%)

M Macy's
$27.30 /

+3.26 (+13.56%)

LTCH Latch
$9.06 /

-1.88 (-17.18%)

LHCG LHC Group
$140.64 /

-4.36 (-3.01%)

INFN Infinera
$7.67 /

-0.4 (-4.96%)

GS Goldman Sachs
$414.61 /

+8.49 (+2.09%)

DIS Disney
$170.73 /

-5.695 (-3.23%)

CDW CDW
$185.50 /

+7.81 (+4.40%)

BTU Peabody Energy
$19.19 /

+3.215 (+20.13%)

BABA Alibaba
$168.41 /

+0.35 (+0.21%)

ACI Albertsons
$29.42 /

+0.9 (+3.16%)

AAPL Apple
$145.33 /

+0.54 (+0.37%)

Z Zillow
$86.60 /

-8.34 (-8.78%)

STT State Street
$96.37 /

+3.63 (+3.91%)

SPCE Virgin Galactic
$19.71 /

-0.29 (-1.45%)

NTAP NetApp
$90.91 /

-3.485 (-3.69%)

NFLX Netflix
$634.29 /

+6.61 (+1.05%)

MDT Medtronic
$121.10 /

-6.55 (-5.13%)

M Macy's
$27.30 /

+3.26 (+13.56%)

LTCH Latch
$9.06 /

-1.88 (-17.18%)

GS Goldman Sachs
$414.61 /

+8.49 (+2.09%)

DIS Disney
$170.73 /

-5.695 (-3.23%)

CDW CDW
$185.50 /

+7.81 (+4.40%)

BTU Peabody Energy
$19.19 /

+3.215 (+20.13%)

BABA Alibaba
$168.41 /

+0.35 (+0.21%)

ASLE AerSale
$18.32 /

+0.37 (+2.06%)

AR Antero Resources
$20.19 /

+0.6 (+3.06%)

ACI Albertsons
$29.42 /

+0.9 (+3.16%)

AAPL Apple
$145.33 /

+0.54 (+0.37%)

AAPL Apple
$145.33 /

+0.54 (+0.37%)

On The Fly
Fly Intel: Pre-market Movers » 08:51
10/18/21
10/18
08:51
10/18/21
08:51
DVAX

Dynavax

$16.94 /

-0.06 (-0.35%)

, OYST

Oyster Point Pharma

$13.65 /

+0.16 (+1.19%)

, ACI

Albertsons

$28.53 /

+0.175 (+0.62%)

, STT

State Street

$92.75 /

+1.045 (+1.14%)

, PHG

Philips

$44.58 /

+0.615 (+1.40%)

, UTHR

United Therapeutics

$187.19 /

-0.24 (-0.13%)

, DIS

Disney

$176.46 /

+1.97 (+1.13%)

, STLA

Stellantis

$19.98 /

+0.145 (+0.73%)

, Z

Zillow

$94.94 /

-0.5 (-0.52%)

, RVNC

Revance

$22.72 /

+0.24 (+1.07%)

, ZG

Zillow Group

$94.30 /

-0.63 (-0.66%)

Check out this morning's…

ShowHide Related Items >><<
Z Zillow
$94.94 /

-0.5 (-0.52%)

UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

STT State Street
$92.75 /

+1.045 (+1.14%)

STLA Stellantis
$19.98 /

+0.145 (+0.73%)

RVNC Revance
$22.72 /

+0.24 (+1.07%)

PHG Philips
$44.58 /

+0.615 (+1.40%)

OYST Oyster Point Pharma
$13.65 /

+0.16 (+1.19%)

DVAX Dynavax
$16.94 /

-0.06 (-0.35%)

DIS Disney
$176.46 /

+1.97 (+1.13%)

ACI Albertsons
$28.53 /

+0.175 (+0.62%)

DVAX Dynavax
$16.94 /

-0.06 (-0.35%)

08/31/21 H.C. Wainwright
Dynavax price target raised to $23 from $20 at H.C. Wainwright
08/05/21 Goldman Sachs
Dynavax initiated with a Buy at Goldman Sachs
08/05/21 H.C. Wainwright
Dynavax price target raised to $20 from $16 at H.C. Wainwright
02/08/21 Evercore ISI
Dynavax had 'big vaccine update week,' says Evercore ISI
OYST Oyster Point Pharma
$13.65 /

+0.16 (+1.19%)

04/23/21 Piper Sandler
Oyster Point has 'most compelling 'dry eye data to date, says Piper Sandler
ACI Albertsons
$28.53 /

+0.175 (+0.62%)

10/11/21
Fly Intel: Top five analyst downgrades
10/11/21 Deutsche Bank
Albertsons price target raised to $36 from $29 at Deutsche Bank
10/11/21 Oppenheimer
Albertsons downgraded to Perform from Outperform at Oppenheimer
10/05/21
Fly Intel: Top five analyst downgrades
STT State Street
$92.75 /

+1.045 (+1.14%)

10/07/21 Wolfe Research
State Street upgraded to Outperform from Peer Perform at Wolfe Research
09/24/21 Deutsche Bank
State Street price target lowered to $111 from $120 at Deutsche Bank
09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
PHG Philips
$44.58 /

+0.615 (+1.40%)

09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
09/08/21
Fly Intel: Top five analyst initiations
09/08/21 Jefferies
Philips initiated with a Buy at Jefferies
08/31/21 ING Bank
Philips upgraded to Buy on recall-related selloff at ING Bank
UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
DIS Disney
$176.46 /

+1.97 (+1.13%)

10/18/21 MoffettNathanson
Disney price target lowered to $180 from $185 at MoffettNathanson
10/18/21 Barclays
Barclays downgrades Disney on slowing of streaming growth
10/18/21 Barclays
Disney downgraded to Equal Weight from Overweight at Barclays
09/28/21 Wells Fargo
Wells Fargo cuts Disney target, sees 'wood to chop' to hit sub outlook
STLA Stellantis
$19.98 /

+0.145 (+0.73%)

09/07/21 KeyBanc
Jeep micro site on Amazon points to auto sales moving online, says KeyBanc
09/03/21 Deutsche Bank
Stellantis deal 'significant opportunity' for Open Lending, says Deutsche Bank
09/02/21 DA Davidson
DA Davidson says Stellantis opportunity for Open Lending not 'fait accompli'
09/02/21 Raymond James
Raymond James says buy Open Lending aggressively after Stellantis deal
Z Zillow
$94.94 /

-0.5 (-0.52%)

09/22/21 Piper Sandler
August home data positive for Zillow and Redfin, says Piper Sandler
08/09/21 Zelman
Zillow upgraded to Buy from Hold at Zelman
08/06/21 Morgan Stanley
Morgan Stanley trims Zillow price target to $153, sees iBuying re-rating lower
07/21/21 Berenberg
Zillow Group initiated with a Buy at Berenberg
RVNC Revance
$22.72 /

+0.24 (+1.07%)

10/18/21 Mizuho
Revance price target lowered to $26 from $36 at Mizuho
10/18/21 H.C. Wainwright
Revance price target lowered to $18 from $26 at H.C. Wainwright
10/13/21 Mizuho
Revance issues in Form 483 'must be very addressable,' says Mizuho
10/13/21 H.C. Wainwright
Revance price target lowered to $26 from $35 at H.C. Wainwright
ZG Zillow Group
$94.30 /

-0.63 (-0.66%)

10/04/21 RBC Capital
Zillow Group price target lowered to $145 from $155 at RBC Capital
09/16/21 BTIG
Zillow Group price target lowered to $145 from $185 at BTIG
08/23/21 Piper Sandler
Home data look positive for Zillow and Redfin, says Piper Sandler
ZG Zillow Group
$94.30 /

-0.63 (-0.66%)

Z Zillow
$94.94 /

-0.5 (-0.52%)

UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

STT State Street
$92.75 /

+1.045 (+1.14%)

STLA Stellantis
$19.98 /

+0.145 (+0.73%)

RVNC Revance
$22.72 /

+0.24 (+1.07%)

PHG Philips
$44.58 /

+0.615 (+1.40%)

DVAX Dynavax
$16.94 /

-0.06 (-0.35%)

DIS Disney
$176.46 /

+1.97 (+1.13%)

ACI Albertsons
$28.53 /

+0.175 (+0.62%)

  • 10
    Sep
Z Zillow
$94.94 /

-0.5 (-0.52%)

STT State Street
$92.75 /

+1.045 (+1.14%)

STLA Stellantis
$19.98 /

+0.145 (+0.73%)

PHG Philips
$44.58 /

+0.615 (+1.40%)

DIS Disney
$176.46 /

+1.97 (+1.13%)

ACI Albertsons
$28.53 /

+0.175 (+0.62%)

ZG Zillow Group
$94.30 /

-0.63 (-0.66%)

Z Zillow
$94.94 /

-0.5 (-0.52%)

UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

STT State Street
$92.75 /

+1.045 (+1.14%)

STLA Stellantis
$19.98 /

+0.145 (+0.73%)

RVNC Revance
$22.72 /

+0.24 (+1.07%)

PHG Philips
$44.58 /

+0.615 (+1.40%)

DVAX Dynavax
$16.94 /

-0.06 (-0.35%)

DIS Disney
$176.46 /

+1.97 (+1.13%)

ACI Albertsons
$28.53 /

+0.175 (+0.62%)

Z Zillow
$94.94 /

-0.5 (-0.52%)

STT State Street
$92.75 /

+1.045 (+1.14%)

OYST Oyster Point Pharma
$13.65 /

+0.16 (+1.19%)

DVAX Dynavax
$16.94 /

-0.06 (-0.35%)

DIS Disney
$176.46 /

+1.97 (+1.13%)

ACI Albertsons
$28.53 /

+0.175 (+0.62%)

Hot Stocks
United Therapeutics receives CRL from FDA declining to approve Tyvaso NDA » 06:09
10/18/21
10/18
06:09
10/18/21
06:09
UTHR

United Therapeutics

$187.19 /

-0.24 (-0.13%)

United Therapeutics…

United Therapeutics announced an update on the FDA review of the new drug application, or NDA, for Tyvaso DPI, for the treatment of pulmonary arterial hypertension, or PAH, and pulmonary hypertension associated with interstitial lung disease, or PH-ILD, to improve exercise capacity. On Friday, October 15, the FDA issued a complete response declining to approve the NDA at this time. The FDA's letter noted only a single deficiency preventing approval of Tyvaso DPI, related to an open inspection issue at a third-party facility that performs analytical testing of treprostinil drug substance. In addition, the FDA did not cite any deficiencies or issues related to operations performed at the MannKind Corporation facility for manufacture, testing, and packaging of finished Tyvaso DPI, including its associated device. All other requests from the agency have been addressed. The draft labeling for Tyvaso DPI, as revised by FDA, includes the same indications as Tyvaso Inhalation Solution for PAH and PH-ILD, to improve exercise ability, and does not contain any contraindications or a boxed warning. The complete response also notes, but does not cite as a deficiency, that the FDA has not yet completed its review of a Citizen's Petition submitted to FDA in July concerning the safety of an excipient in Tyvaso DPI.

ShowHide Related Items >><<
UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

Hot Stocks
MannKind provides progress update on Tyvaso DPI New Drug Application » 06:05
10/18/21
10/18
06:05
10/18/21
06:05
MNKD

MannKind

$5.10 /

-0.2 (-3.77%)

, UTHR

United Therapeutics

$187.19 /

-0.24 (-0.13%)

MannKind (MNKD) has…

MannKind (MNKD) has learned that the FDA issued a complete response to United Therapeutics (UTHR) regarding the New Drug Application for Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The FDA declined to approve the NDA at this time, noting only one deficiency related to an open inspection issue at a third-party analytical testing center for treprostinil drug substance, the active ingredient of Tyvaso DPI. The complete response did not pertain to MannKind, and no issues were cited by the FDA as it relates to MannKind's facility in Connecticut for manufacturing, testing and packaging of finished Tyvaso DPI, including its associated device.

ShowHide Related Items >><<
UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

MNKD MannKind
$5.10 /

-0.2 (-3.77%)

MNKD MannKind
$5.10 /

-0.2 (-3.77%)

05/13/21 RBC Capital
MannKind initiated with a Sector Perform at RBC Capital
02/26/21 H.C. Wainwright
MannKind price target raised to $6.50 from $2.50 at H.C. Wainwright
02/24/21 BTIG
MannKind price target raised to $8 from $4 at BTIG
12/29/20 BTIG
United Therapeutics' treprostinil development uses MannKind technology, say BTIG
UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
UTHR United Therapeutics
$187.19 /

-0.24 (-0.13%)

MNKD MannKind
$5.10 /

-0.2 (-3.77%)

MNKD MannKind
$5.10 /

-0.2 (-3.77%)

Conference/Events
FDA PDUFA Date for United Therapeutics Tyvaso DPI is October 15, 2021  09:46
10/15/21
10/15
09:46
10/15/21
09:46
UTHR

United Therapeutics

$187.00 /

-0.43 (-0.23%)

 
ShowHide Related Items >><<
UTHR United Therapeutics
$187.00 /

-0.43 (-0.23%)

UTHR United Therapeutics
$187.00 /

-0.43 (-0.23%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
UTHR United Therapeutics
$187.00 /

-0.43 (-0.23%)

UTHR United Therapeutics
$187.00 /

-0.43 (-0.23%)

Hot Stocks
Liquidia says PTAB rules in its favor in review against UTC patent » 17:25
10/08/21
10/08
17:25
10/08/21
17:25
LQDA

Liquidia Technologies

$2.73 /

-0.02 (-0.73%)

, UTHR

United Therapeutics

$195.58 /

-0.535 (-0.27%)

Liquidia Corporation…

Liquidia Corporation (LQDA) announced that the U.S. Patent Trial and Appeal Board ruled in its favor in the Inter Partes Review proceeding against U.S. Patent No. 9,604,901 owned by United Therapeutics Corporation (UTHR) and listed in the Orange Book for Tyvaso. In its ruling, the PTAB found that seven of the nine claims were unpatentable. Only the narrower dependent claims 6 and 7 remain, both of which require actual storage at ambient temperature of treprostinil sodium. The PTAB's decision primarily relates to the issue of patentability based on a review of prior art. This decision does not preclude the invalidation of the remaining claims on other grounds as part of the ongoing Hatch Waxman litigation, nor does it mean that Liquidia infringes either of the surviving claims. Damian deGoa, President and Chief Executive Officer of Liquidia said: "We are very pleased with this decision by the PTAB. This is a clear win in our on-going patent dispute with United Therapeutics, and we remain confident that we will ultimately prevail on all patent claims they have asserted against us. We will continue to vigorously defend our right to commercialize LIQ861 as soon as possible."

ShowHide Related Items >><<
UTHR United Therapeutics
$195.58 /

-0.535 (-0.27%)

LQDA Liquidia Technologies
$2.73 /

-0.02 (-0.73%)

LQDA Liquidia Technologies
$2.73 /

-0.02 (-0.73%)

12/04/20
Fly Intel: Top five analyst initiations
12/04/20 H.C. Wainwright
Liquidia Technologies initiated with a Buy at H.C. Wainwright
11/20/20
Fly Intel: Top five analyst downgrades
11/20/20 Wedbush
Liquidia Technologies downgraded to Neutral from Outperform at Wedbush
UTHR United Therapeutics
$195.58 /

-0.535 (-0.27%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
UTHR United Therapeutics
$195.58 /

-0.535 (-0.27%)

LQDA Liquidia Technologies
$2.73 /

-0.02 (-0.73%)

UTHR United Therapeutics
$195.58 /

-0.535 (-0.27%)

Over a month ago
Conference/Events
United Therapeutics management to meet virtually with Oppenheimer » 04:55
09/14/21
09/14
04:55
09/14/21
04:55
UTHR

United Therapeutics

$209.83 /

-0.5 (-0.24%)

Virtual Meeting to be…

Virtual Meeting to be held on September 14 hosted by Oppenheimer.

ShowHide Related Items >><<
UTHR United Therapeutics
$209.83 /

-0.5 (-0.24%)

UTHR United Therapeutics
$209.83 /

-0.5 (-0.24%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
UTHR United Therapeutics
$209.83 /

-0.5 (-0.24%)

UTHR United Therapeutics
$209.83 /

-0.5 (-0.24%)

Conference/Events
United Therapeutics management to meet virtually with Oppenheimer » 13:55
09/08/21
09/08
13:55
09/08/21
13:55
UTHR

United Therapeutics

$208.40 /

+0.51 (+0.25%)

Virtual Meeting to be…

Virtual Meeting to be held on September 14 hosted by Oppenheimer.

ShowHide Related Items >><<
UTHR United Therapeutics
$208.40 /

+0.51 (+0.25%)

UTHR United Therapeutics
$208.40 /

+0.51 (+0.25%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
UTHR United Therapeutics
$208.40 /

+0.51 (+0.25%)

UTHR United Therapeutics
$208.40 /

+0.51 (+0.25%)

Hot Stocks
United Therapeutics presents new Tyvaso DPI data at ERS » 06:13
09/07/21
09/07
06:13
09/07/21
06:13
UTHR

United Therapeutics

$210.72 /

-1.42 (-0.67%)

United Therapeutics…

United Therapeutics presented new clinical data from the BREEZE study evaluating Tyvaso DPI in patients with pulmonary arterial hypertension, or PAH, at the European Respiratory Society, or ERS, International Congress. Top line data showing the BREEZE study met its primary objective were released in January. Secondary objectives of the study included changes in six-minute walk distance, or 6MWD, device preference and satisfaction as evaluated through the Preference Questionnaire for Inhaled Treprostinil Devices, or PQ-ITD, and patient reported PAH symptoms and impact, or PAH-SYMPACT. Three weeks after switching from Tyvaso to Tyvaso DPI, patients in the BREEZE study demonstrated: significant improvements in 6MWD compared to baseline. improvements of 11.5 meters in 6MWD compared to baseline were observed through the three-week treatment phase. Significant improvements in overall satisfaction with the Tyvaso DPI inhaler. Using the PQ-ITD, significant improvements were observed in overall satisfaction with the Tyvaso DPI inhaler. Significant improvements in PAH Impact. The SYMPACT questionnaire includes domains on physical impacts, cognitive/emotional impacts, cardiopulmonary symptoms, and cardiovascular symptoms. Significant improvements in PAH impacts were observed in physical impacts and cognitive/emotional impacts at week three. Subjects in BREEZE were given the opportunity to continue in an optional extension phase, or OEP. All subjects who completed the treatment phase elected to continue in the OEP. Improvements in 6MWD compared to baseline were sustained in the OEP through the data cut-off date.

ShowHide Related Items >><<
UTHR United Therapeutics
$210.72 /

-1.42 (-0.67%)

UTHR United Therapeutics
$210.72 /

-1.42 (-0.67%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
07/14/21 Argus
United Therapeutics upgraded to Buy from Hold at Argus
05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
UTHR United Therapeutics
$210.72 /

-1.42 (-0.67%)

UTHR United Therapeutics
$210.72 /

-1.42 (-0.67%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.